%0 Journal Article
%T Estado actual del trasplante card¨ªaco en Nuevo Le¨®n: Primeros 33 casos: Programas de Trasplante Card¨ªaco de la Unidad M¨¦dica de Alta Especialidad No. 34 del IMSS, del Hospital San Jos¨¦ TEC de Monterrey y Hospital Christus Muguerza
%A Herrera Garza
%A Eduardo
%A Molina Gamboa
%A Julio
%A Decanini Arcaute
%A Horacio
%A Ibarra Flores
%A Marcos
%A Torres Garc¨ªa
%A Myrella
%A Mac¨ªas Hidalgo
%A Carlos
%A Gonz¨¢lez Oviedo
%A Roberto
%A de la Fuente Magallanes
%A Felipe de Jes¨²s
%A Elizondo Sifuentes
%A Luis ¨¢ngel
%A Villarreal Arredondo
%A Miguel ¨¢ngel
%A Ortega Duran
%A ¨®scar
%A Mart¨ªnez Berm¨²dez
%A Pedro
%A Garc¨ªa Castillo
%A Armando
%A Becerra Garc¨ªa
%A Oralia
%A Mart¨ªnez Rodr¨ªguez
%A Diana
%A Contreras Lara
%A Carmen
%A Olivares de la Cerda
%A Mar¨ªa del Consuelo
%A Trevi£¿o Trevi£¿o
%A Alfonso
%J Archivos de cardiolog¨ªa de M¨¦xico
%D 2006
%I Scientific Electronic Library Online
%X heart failure is one of the most important causes of death worldwide. heart transplant is the last effective alternative when the medical and surgical treatments have failed in patients with end stage heart failure, giving them an 80% one year survival rate. unfortunately, during the outcome, the heart transplant patients can develop complications such as graft rejection and opportunistic infections because of the use of immunosuppressive therapy. in the present article we report the experience with 33 heart transplant patients. our program not only has successfully transplanted patients with advanced age but, for the first time in latin america we have transplanted patients assisted with the ambulatory thoratec tlc ii system. even with limited resources, we have managed the same complications than other heart transplant programs, our 82% one year survival rate is similar than reports in medical literature.
%K heart transplant
%K sirolimus
%K basiliximab.
%U http://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S1405-99402006000200004&lng=en&nrm=iso&tlng=en